Study to Investigate the Absorption, Metabolism and Excretion of [14C] ASP2215 in Patients With Advanced Solid Tumors
Clinical trial NCT02456883 · COMPLETED
Trial details
- NCT number
- NCT02456883
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-04
- Primary completion
- 2017-05-20
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.